The alliance-outcome relationship in individual psychotherapy for early psychosis: a secondary analysis of a randomized clinical trial

被引:0
|
作者
Stiles, Bryan J. [1 ]
Orleans-Pobee, Maku [1 ]
Bullard, Katherine [1 ]
Halverson, Tate F. [2 ]
Meyer-Kalos, Piper S. [3 ]
Perkins, Diana [4 ]
Penn, David L. [4 ,5 ]
Browne, Julia [6 ,7 ]
机构
[1] Univ North Carolina Chapel Hill, Dept Psychol & Neurosci, Chapel Hill, NC USA
[2] Durham VA Healthcare Syst, VA Midatlantic Mental Illness Res Educ & Clin Ctr, Durham, NC USA
[3] Univ Minnesota, Dept Psychiat & Behav Sci, Med Sch, Minneapolis, MN USA
[4] Univ North Carolina Chapel Hill, Dept Psychiat, Chapel Hill, NC USA
[5] Australian Catholic Univ, Sch Behav & Hlth Sci, Melbourne, Vic, Australia
[6] VA Providence Healthcare Syst, Ctr Innovat Long Term Serv & Supports, Providence, RI USA
[7] Brown Univ, Dept Psychiat & Human Behav, Alpert Med Sch, Providence, RI USA
关键词
Working alliance; therapy outcomes; schizophrenia; mindfulness interventions; THERAPEUTIC ALLIANCE; WORKING ALLIANCE; PSYCHOLOGICAL THERAPY; SCHIZOPHRENIA; PREDICT; PEOPLE; PANSS;
D O I
10.1080/17522439.2024.2385832
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
BackgroundStudies of the alliance-outcome relationship in psychosocial treatments for early psychosis are limited both in number and design, with few utilizing subjective measures as outcomes, multiple alliance timepoints or existing benchmarks to distinguish high or low levels of the alliance. We addressed these gaps in the context of a pilot randomized controlled psychotherapy trial for early psychosis.MethodsTwenty-eight clients with early psychosis completed alliance ratings at mid-treatment (4.5 months) and post-treatment (9 months). We tested the alliance-outcome relationship through change scores between mid- and post-treatment and the use of a pre-defined benchmark to distinguish high versus low mid-treatment alliance. We also examined baseline differences between levels of the alliance. Outcomes included objective and subjective targets.ResultsChange in the alliance did not predict any outcomes at post-treatment. Clients with high mid-treatment alliance had lower perceived stress and higher psychological well-being at post-treatment. At baseline, clients with high alliance had lower negative symptoms and loneliness as well as higher community functioning and well-being.DiscussionUse of an empirical alliance benchmark may help identify early psychosis clients who need additional support in alliance formation as well as facilitate positive psychotherapy outcomes
引用
收藏
页码:35 / 46
页数:12
相关论文
共 50 条
  • [21] Effects of Actissist, a digital health intervention for early psychosis: A randomized clinical trial
    Bucci, Sandra
    Berry, Natalie
    Ainsworth, John
    Berry, Katherine
    Edge, Dawn
    Eisner, Emily
    Emsley, Richard
    Forbes, Gordon
    Hassan, Lamiece
    Lewis, Shon
    Machin, Matthew
    Haddock, Gillian
    PSYCHIATRY RESEARCH, 2024, 339
  • [22] The Effects of Relationship and Progress Feedback in Group Psychotherapy Using the Group Questionnaire and Outcome Questionnaire-45: A Randomized Clinical Trial
    Burlingame, Gary M.
    Whitcomb, Kaitlyn E.
    Woodland, Sean C.
    Olsen, Joseph A.
    Beecher, Mark
    Gleave, Robert
    PSYCHOTHERAPY, 2018, 55 (02) : 116 - 131
  • [23] The relationship between the therapeutic alliance and client variables in individual treatment for schizophrenia spectrum disorders and early psychosis: Narrative review
    Browne, Julia
    Nagendra, Arundati
    Kurtz, Matthew
    Berry, Katherine
    Penn, David L.
    CLINICAL PSYCHOLOGY REVIEW, 2019, 71 : 51 - 62
  • [24] Association of Individual-Level Factors With Visual Outcomes in Optic Neuritis Secondary Analysis of a Randomized Clinical Trial
    De Lott, Lindsey B.
    Burke, James F.
    Andrews, Chris A.
    Costello, Fiona
    Cornblath, Wayne T.
    Trobe, Jonathan D.
    Lee, Paul P.
    Kerber, Kevin A.
    JAMA NETWORK OPEN, 2020, 3 (05)
  • [25] The Association of Therapeutic Alliance With Long-Term Outcome in a Guided Internet Intervention for Depression: Secondary Analysis From a Randomized Control Trial
    Penedo, Juan Martin Gomez
    Babl, Anna Margarete
    Holtforth, Martin Grosse
    Hohagen, Fritz
    Krieger, Tobias
    Lutz, Wolfgang
    Meyer, Bjorn
    Moritz, Steffen
    Klein, Jan Philipp
    Berger, Thomas
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2020, 22 (03)
  • [26] Reduction of Crime in First-Onset Psychosis: A Secondary Analysis of the OPUS Randomized Trial
    Stevens, Hanne
    Agerbo, Esben
    Dean, Kimberlie
    Mortensen, Preben B.
    Nordentoft, Merete
    JOURNAL OF CLINICAL PSYCHIATRY, 2013, 74 (05) : E439 - E444
  • [27] Transgender and nonbinary patients? psychotherapy goals: A secondary analysis from a randomized controlled trial
    Budge, Stephanie L.
    Schoenike, Darren
    Lee, Joonwoo
    Norton, Marquel
    Sinnard, Morgan T.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2023, 159 : 82 - 86
  • [28] Essential Fatty Acid Supplementation and Early Inflammation in Preterm Infants: Secondary Analysis of a Randomized Clinical Trial
    Wendel, Kristina
    Gunnarsdottir, Gunnthorunn
    Aas, Marlen Fossan
    Westvik, Asbjorn Schumacher
    Pripp, Are Hugo
    Fugelseth, Drude
    Stiris, Tom
    Moltu, Sissel Jennifer
    NEONATOLOGY, 2023, 120 (04) : 465 - 472
  • [29] Validation of modified GLIM criteria to predict adverse clinical outcome and response to nutritional treatment: A secondary analysis of a randomized clinical trial
    Kaegi-Braun, Nina
    Boesiger, Fabienne
    Tribolet, Pascal
    Gomes, Filomena
    Kutz, Alexander
    Hoess, Claus
    Pavlicek, Vojtech
    Bilz, Stefan
    Sigrist, Sarah
    Braendle, Michael
    Henzen, Christoph
    Thomann, Robert
    Rutishauser, Jonas
    Aujesky, Drahomir
    Rodondi, Nicolas
    Donze, Jacques
    Stanga, Zeno
    Lobo, Dileep N.
    Cederholm, Tommy
    Mueller, Beat
    Schuetz, Philipp
    CLINICAL NUTRITION, 2022, 41 (04) : 795 - 804
  • [30] Using an interim analysis based exclusively on an early outcome in a randomized clinical trial with a long-term clinical endpoint
    Barrado, Leandro Garcia
    Burzykowski, Tomasz
    Legrand, Catherine
    Buyse, Marc
    PHARMACEUTICAL STATISTICS, 2022, 21 (01) : 209 - 219